Evidence map›Paper›PMID 25032866›Full record

ArticleCell death & disease2014

Bim is a crucial regulator of apoptosis induced by Mycobacterium tuberculosis.

N Aguiló, S Uranga, D Marinova, C Martín, J Pardo

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Cell death pathways in response toInfection and immunity · 2025
    Review
  3. Article
  4. Review
  5. mBio · 2023
    Article
  6. Article
  7. Different modalities of host cell death and their impact onAmerican journal of physiology. Cell physiology · 2022
    Review
  8. Metabolite Dysregulation by Pranlukast inMolecules (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Review
  11. Frontiers in cellular and infection microbiology · 2021
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. An allosteric inhibitor ofEMBO molecular medicine · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

N Aguiló1] Grupo de Genética de Micobacterias. Dpto. Microbiología, Medicina Preventiva y Salud Pública, Facultad de Medicina, Universidad de Zaragoza, C/ Domingo Miral s/n, 50009 Zaragoza, Spain [2] CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
S Uranga1] Grupo de Genética de Micobacterias. Dpto. Microbiología, Medicina Preventiva y Salud Pública, Facultad de Medicina, Universidad de Zaragoza, C/ Domingo Miral s/n, 50009 Zaragoza, Spain [2] CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
D Marinova1] Grupo de Genética de Micobacterias. Dpto. Microbiología, Medicina Preventiva y Salud Pública, Facultad de Medicina, Universidad de Zaragoza, C/ Domingo Miral s/n, 50009 Zaragoza, Spain [2] CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
C Martín1] Grupo de Genética de Micobacterias. Dpto. Microbiología, Medicina Preventiva y Salud Pública, Facultad de Medicina, Universidad de Zaragoza, C/ Domingo Miral s/n, 50009 Zaragoza, Spain [2] CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain [3] Servicio de Microbiología, Hospital Universitario Miguel Servet, ISS Aragón, Paseo Isabel la Católica 1-3, 50009 Zaragoza, Spain.
J Pardo1] Grupo Apoptosis, Inmunidad y Cáncer, Dpto. Bioquímica y Biología Molecular y Celular, Fac. Ciencias, Universidad de Zaragoza, Zaragoza, Spain [2] Cell Immunity in Inflammation, Infection and Cancer Group, Department Biochemistry and Molecular and Cell Biology, University of Zaragoza, Zaragoza, Spain [3] Immune Effector Cells Group (ICE), Aragón Health Research Institute (IIS Aragón), Edificio CIBA, Biomedical Research Centre of Aragón (CIBA), Zaragoza, Spain [4] Nanoscience Institute of Aragon (INA), University of Zaragoza, Zaragoza, Spain [5] Fundación Aragón I+D (ARAID), Gobierno de Aragón, Zaragoza, Spain.
Universidad de Zaragoza · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycobacterium tuberculosis, the causative agent of tuberculosis, induces apoptosis in infected macrophages in vitro and in vivo. However, the molecular mechanism controlling this process is not known. In order to study the involvement of the mitochondrial apoptotic pathway in M. tuberculosis-induced apoptosis, we analysed cell death in M. tuberculosis-infected embryonic fibroblasts (MEFs) derived from different knockout mice for genes involved in this route. We found that apoptosis induced by M. tuberculosis is abrogated in the absence of Bak and Bax, caspase 9 or the executioner caspases 3 and 7. Notably, we show that MEF deficient in the BH3-only BCL-2-interacting mediator of cell death (Bim) protein were also resistant to this process. The relevance of these results has been confirmed in the mouse macrophage cell line J774, where cell transfection with siRNA targeting Bim impaired apoptosis induced by virulent mycobacteria. Notably, only infection with a virulent strain, but not with attenuated ESX-1-defective strains, such as Bacillus Calmette-Guerin and live-attenuated M. tuberculosis vaccine strain MTBVAC, induced Bim upregulation and apoptosis, probably implicating virulence factor early secreted antigenic target 6-kDa protein in this process. Our results suggest that Bim upregulation and apoptosis is mediated by the p38MAPK-dependent pathway. Our findings show that Bim is a master regulator of apoptosis induced by M. tuberculosis.

Indexed as

ApoptosisAnimalsApoptosis Regulatory Proteinsbcl-2-Associated X ProteinBcl-2-Like Protein 11Caspase 3FemaleHost-Pathogen InteractionsHumansMembrane ProteinsMiceMice, KnockoutMitochondriaMycobacterium tuberculosisProto-Oncogene ProteinsTuberculosisApoptosis Regulatory Proteinsbcl-2-Associated X ProteinBCL2L11 protein, humanBcl2l11 protein, mouseBcl-2-Like Protein 11Caspase 3Membrane ProteinsProto-Oncogene Proteins

Identifiers

PMID25032866
PMCPMC4123102
OpenAlexW2016906151

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.